Chronic myeloid leukemia (CML) is a type of blood cancer that begins in the bone marrow and affects the cells that produce white blood cells. It is typically a slow-growing disease that develops when a genetic change causes the bone marrow to produce too many abnormal white blood cells. Advances in targeted therapies have transformed the treatment of CML, allowing many people to achieve long-term disease control and maintain a good quality of life.
CLL develops when abnormal B lymphocytes grow and survive longer than normal.
Over time, these abnormal cells can:
CLL is one of the most common types of leukemia in adults and typically progresses slowly.
Some people have no symptoms at diagnosis, while others may experience:
Symptoms vary depending on the stage and activity of the disease.
Factors associated with an increased risk of CLL include:
The exact cause of CLL is not fully understood, and many people have no identifiable risk factors.
Diagnosis typically involves several laboratory and imaging tests, including:
These tests help confirm the diagnosis and guide treatment planning.
Not everyone with CLL requires immediate treatment. Individuals without symptoms may be monitored through an approach known as active surveillance or watchful waiting.
When treatment becomes necessary, options may include:
Treatment recommendations depend on disease stage, genetic findings, symptoms, and overall health.
Regular follow-up appointments help assess disease progression and treatment response.
Monitoring may include:
Routine monitoring helps determine when treatment should begin or be adjusted.
Many people with CLL live for years with careful medical management.
Healthy habits that support overall well-being include:
These measures complement medical treatment and ongoing monitoring.
Prompt medical evaluation is recommended if symptoms include:
Early evaluation can help identify disease progression or treatment-related complications.
Chronic lymphocytic leukemia is a slow-growing blood cancer that often requires individualized care and long-term monitoring. While some people may not need immediate treatment, others benefit from modern targeted therapies, immunotherapy, and other advanced treatment approaches. Early diagnosis, regular follow-up, and personalized care from a hematology specialist play important roles in managing CLL and maintaining quality of life.